190 related articles for article (PubMed ID: 12062899)
1. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling.
Kemp DM; Ubeda M; Habener JF
Mol Cell Endocrinol; 2002 Jun; 191(2):157-66. PubMed ID: 12062899
[TBL] [Abstract][Full Text] [Related]
2. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1.
Peschke E; Mühlbauer E; Musshoff U; Csernus VJ; Chankiewitz E; Peschke D
J Pineal Res; 2002 Sep; 33(2):63-71. PubMed ID: 12153439
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
Kemp DM; Habener JF
Biochem Pharmacol; 2002 Aug; 64(4):689-97. PubMed ID: 12167488
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
Chepurny OG; Holz GG
Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Mel 1a melatonin receptor mRNA and protein levels in the ovine pars tuberalis: evidence for a cyclic adenosine 3',5'-monophosphate-independent Mel 1a receptor coupling and an autoregulatory mechanism of expression.
Barrett P; MacLean A; Davidson G; Morgan PJ
Mol Endocrinol; 1996 Jul; 10(7):892-902. PubMed ID: 8813729
[TBL] [Abstract][Full Text] [Related]
6. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
Fehmann HC; Habener JF
FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
[TBL] [Abstract][Full Text] [Related]
7. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
Hui H; Yu R; Bousquet C; Perfetti R
Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
[TBL] [Abstract][Full Text] [Related]
8. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
Laychock SG
Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
[TBL] [Abstract][Full Text] [Related]
9. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
10. Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.
Fehmann HC; Janssen M; Göke B
Acta Diabetol; 1995 Oct; 32(3):176-81. PubMed ID: 8590787
[TBL] [Abstract][Full Text] [Related]
11. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).
Holz GG; Leech CA; Heller RS; Castonguay M; Habener JF
J Biol Chem; 1999 May; 274(20):14147-56. PubMed ID: 10318832
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
Skoglund G; Hussain MA; Holz GG
Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic, and molecular investigations.
Peschke E; Fauteck JD; Musshoff U; Schmidt F; Beckmann A; Peschke D
J Pineal Res; 2000 Apr; 28(3):156-64. PubMed ID: 10739302
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
15. Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion.
Kashima Y; Miki T; Shibasaki T; Ozaki N; Miyazaki M; Yano H; Seino S
J Biol Chem; 2001 Dec; 276(49):46046-53. PubMed ID: 11598134
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
Waeber G; Thompson N; Waeber B; Brunner HR; Nicod P; Grouzmann E
Endocrinology; 1993 Sep; 133(3):1061-7. PubMed ID: 8396008
[TBL] [Abstract][Full Text] [Related]
17. Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction.
Fehmann HC; Bode HP; Ebert T; Karl A; Göke B
Horm Metab Res; 1997 Nov; 29(11):572-6. PubMed ID: 9479558
[TBL] [Abstract][Full Text] [Related]
18. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
Gromada J; Ding WG; Barg S; Renström E; Rorsman P
Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
[TBL] [Abstract][Full Text] [Related]
19. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
Widmann C; Bürki E; Dolci W; Thorens B
Mol Pharmacol; 1994 May; 45(5):1029-35. PubMed ID: 8190093
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of incretin hormones on insulin release from pancreatic islets in the bile duct-ligated rats.
Niwa T; Nimura Y; Niki I
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E59-64. PubMed ID: 11120659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
